ZCCHC7 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of zinc finger CCHC-type containing protein 7 (ZCCHC7), a protein known for its role in RNA metabolism, particularly in the regulation of RNA decay and processing. ZCCHC7 is a component of the nuclear exosome, a multiprotein complex responsible for degrading and processing various types of RNA, including misprocessed or non-functional RNA molecules. ZCCHC7 contains CCHC zinc finger motifs, which are crucial for its ability to bind RNA and interact with other proteins within the exosome complex. These zinc finger motifs depend on the coordination of zinc ions to maintain their structural integrity. Inhibitors of ZCCHC7 interfere with its RNA-binding activity or disrupt its interactions within the exosome complex, leading to altered RNA turnover and potentially affecting cellular RNA homeostasis.
The mechanisms by which ZCCHC7 inhibitors function can vary depending on their chemical structure. One common mechanism involves disrupting the zinc finger motifs that are essential for the RNA-binding capability of ZCCHC7. By binding to these zinc finger domains, the inhibitors destabilize the protein's structure, preventing it from interacting effectively with RNA molecules or participating in the RNA degradation process. Other inhibitors may target the interactions between ZCCHC7 and other proteins within the nuclear exosome complex, blocking the assembly or function of the exosome. This inhibition prevents ZCCHC7 from fulfilling its role in regulating RNA degradation and processing. By inhibiting ZCCHC7, these compounds provide insights into the broader mechanisms of RNA regulation and the role of RNA-binding proteins in maintaining cellular RNA balance. Studying ZCCHC7 inhibitors is crucial for understanding the complex processes of RNA decay and turnover, which are vital for controlling gene expression and ensuring cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA synthesis, potentially affecting ZCCHC7's RNA-related functions. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially reducing the transcription of genes regulated by ZCCHC7. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA Polymerase II, can decrease transcription affecting ZCCHC7's regulatory roles. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export by binding to exportin 1, possibly affecting ZCCHC7's nucleocytoplasmic transport. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Inhibits spliceosome function, potentially impacting ZCCHC7 if involved in pre-mRNA splicing. | ||||||
Isoquinoline | 119-65-3 | sc-255224 sc-255224A | 5 g 100 g | $26.00 $58.00 | ||
Can affect various signaling pathways, potentially modulating ZCCHC7's activity indirectly. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Intercalates DNA and inhibits topoisomerase II, potentially influencing ZCCHC7's DNA-associated functions. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Inhibits nucleic acid synthesis and can interfere with DNA-binding proteins, affecting ZCCHC7 indirectly. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, which can impact ZCCHC7 if it is involved in DNA replication or repair processes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Targets topoisomerase II, possibly affecting ZCCHC7's involvement with chromatin structure and function. | ||||||